ClinicalTrials.Veeva

Menu

Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Urothelial Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT00867633
200804011R

Details and patient eligibility

About

To study the association between aristolochic acid and urothelial carcinoma in Taiwan

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • the resected kidney tissue in the tissue bank

Exclusion criteria

  • the patients who had been ever exposed to arsenics, rubber, chemicals, irradiation for pelvis, or received chemotherapy.

Trial design

100 participants in 3 patient groups

Urothelial carcinoma
Description:
The DNA samples extracted from the urothelial carcinoma tissue
RCC
Description:
the DNA sample extracted from RCC
Non-cancer
Description:
The DNA sample extracted from the non-cancerous kidney tissue

Trial contacts and locations

1

Loading...

Central trial contact

Yeong-Shiau Pu, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems